tirzepatide home kit Homekit SDV How to Inject Tirzepatide
Description
The dose is further escalated (titrated) by increasing by 2.5 mg every 4 weeks until reaching the maintenance dosage
Tirzepatide 20 mg is a dual-agonist peptide that acts on both GLP-1 and GIP receptors to support metabolic research, glucose regulation, and weight management studies
Mar 21, 2026 I'm a client and I have lost 24 lbs
Studies suggest Tirzepatide may lead to greater weight loss than GLP-1 for some patients
Some individuals may use it short-term to reach a specific goal, while others may continue treatment longer for ongoing weight management
Scientific References Ozempic, INN-semaglutide - EPAR Product Information
